Companies Related to "Role Response Perceptions Couples Ongoing Cancer Related Disclosure" [Most Relevant Company Matches] [Advanced Search Results] RSS

13:57 EST 20th January 2019 | BioPortfolio

Here are the most relevant search results for "Role Response Perceptions Couples Ongoing Cancer Related Disclosure" found in our extensive corporate database of over 50,000 company records.

Showing "Role Response Perceptions Couples Ongoing Cancer Related Disclosure" Companies 1–25 of 5,000+


Biothera Pharmaceuticals, Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a clinical stage immunotherapy drug that modulates key immune cells to orchestrate a coordinated immune response to cancer that involves both the innate and adaptive immune system. Proof of concept has been established from single-arm and randomized phase 2 studies in non-small cell...


KIYATEC is changing the future of cancer care by accurately predicting patient-specific response and non-response to chemotherapy drugs before treatment begins. Wasted time is the enemy of cancer patients and there is currently no way to accurately predict which cancer patients will respond to standard oncology treatments. KIYATEC has developed a validated...

Quentis Therapeutics Inc.

Quentis Therapeutics is a preclinical stage biotechnology company that is pursuing first-in-class endoplasmic reticulum (ER) stress response-targeted therapies to address serious diseases such as cancer. Based on our deep expertise in ER stress biology and the tumor microenvironment, we are pioneering the use of ER stress response modulators to boost the i...

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understanding of biotechnology and the life sciences throughout Europe. The objectives are to advance the public debate on biotechnology and to facilitate dialogue between interested parties.

Supportive Solutions, Inc.

Supportive Solutions, Inc. (SSI) is dedicated to setting the standard for providing crisis response services to the business community while providing ongoing support and services to crisis consultants. Our approach to crisis response combines leading-edge practices with a commitment to excellence.To create standards of practice and deliver crisis response services that will be held up as a benchm...

The Gottman Institute, Inc.

The Gottman Institute, co-founded by Drs. John and Julie Schwartz Gottman, has two major functions. The Institute helps couples directly, and it provides state-of-the-art training to mental health professionals and other health care providers. The Gottman Institute applies leading-edge research on marriage in a practical, down-to-earth therapy and trains therapists committed to helping couples. No...

Biothera Pharmaceutical Inc.

Biothera is a privately held biotechnology company developing Imprime PGG, a late clinical stage immunotherapeutic drug candidate that modulates key immune cells to recognize and kill cancer. Proof of concept has been established from single-arm and randomized Phase 2 studies in non-small cell lung cancer (NSCLC), colorectal cancer, and chronic lymp...

BSD Medical

BSD Medical Corporation (AMEX: BSM) develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy. BSD Medical is also making major progress in the application of its technology for other therapies. Microwave and RF hyperthermia therapy has been shown to substantially improve local con...

Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation is a 501(c)(3) non-profit organization with a mission to create national and global awareness of the potentials of the Kanzius Noninvasive Radiowave Cancer Treatment, and to help accelerate the speed at which this research progresses to human trials. The goal of KCRF is to raise money to support ongoing research grants. Pancreatic, liver and colorectal cance...

Access to Nutrition Index

The 2016 Index concluded that, while some companies have taken positive steps since the last Index, the industry as a whole is moving far too slowly. Scored out of ten on their nutrition-related commitments, practices and levels of disclosure, no company achieved a score of more than 6.4.

Swiss Vaccine Research Institute

The SVRI is a partnership of five research institutes in Switzerland. The SVRI was created in 2007 in Lausanne and is supported by the Swiss Secretariat of Education and Research. Its primary objective is to develop effective preventive vaccine strategies and therapeutic vaccine interventions for infectious diseases and for cancer. SVRI plays an instrument...

Samuel Oschin Comprehensive Cancer Institute

The Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center is both sophisticated and patient-centered, comprehensive and specialized. Under the wide umbrella of the Samuel Oschin Comprehensive Cancer Institute are many specialized cancer treatment programs. Our physicians, oncologists, radiologists, nurses, rehabilitation therapy specialists and allied health professionals wor...

Church & Dwight, Co., Inc.

Church and Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response Early Result Pregnancy Test and other First Response products, including First Response Gold Digital, First Response Rapid Result Pregnancy Test, First Response Easy Read Ovulation Test, First Response Daily Ovulation Test, First Response Fertility Test for Women, and Answer Pregnancy and Ovulation Tests.


BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies and anti-HIV agents. The company’s initial focus is on cancer, where it capitalizing on two recent scientific advances: the discovery that a complex natural product, bryostatin, stimulates tumor antigen production to amplify the ...

Quentis Therapeutics

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on our deep expertise in endoplasmic reticulum (ER) stress biology and the tumor microenvironment, we are pioneering first-in-class ER stress response modulators t...

The Rumbaugh-Goodwin Institute for Cancer Research, Inc

The Rumbaugh-Goodwin Institute for Cancer Research, Inc. (RGI) is a not-for-profit research organization founded by Dr. James Reyniers in 1959. Historically, the genesis of RGI was through the LOBUND Institute of the University of Notre Dame, where Dr. Reyniers developed barrier-containment technology. This advance enabled the breeding of small germ-free animals with eventual application of the pl...

Jennerex, Inc.

Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594 is currently in two mid-stage clinical trials in patients with primary liver cancer -- an international, randomized, Phase 2 dose-response clinical trial, and a Phase 2 study in combina...

Cancer Support Community

The Cancer Support Community's Research and Training Institute examines the critical role of social and emotional support for those living with cancer and studies the distinctive needs of survivors and caregivers throughout each phase of the cancer experience, as well as post treatment. Focused on research and education, this vibrant resource enables the Cancer Support Community to conduct peer-r...

Cancer Commons

Cancer Commons is a non‐profit open science initiative dedicated to improving outcomes for today’s cancer patients. Our goals are to: 1) give each patient the best possible outcome by individualizing their treatment based on their tumor’s genomic subtype; 2) learn as much as possible from each patient’s response, and 3) rapidly disseminate wha...

Solutions for Intimacy

Solutions for Intimacy is a comprehensive program providing couples with the tools, resources and knowledge to live a sexually fulfilling life after prostate cancer. It was founded in 2011 by husband-and-wife-team Steve Frohman and Cindie Hubiak, following Frohman’s battle with the disease. For more information, visit

Brooklyn ImmunoTherapeutics LLC

Brooklyn ImmunoTherapeutics (formerly IRX Therapeutics) is focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies.

Conceivex, Inc.

The mission of Conceivex, Inc. is to give women and couples healthcare products that assist them in reaching their reproductive goals. Currently, one in six women is looking for help becoming pregnant. Conceivex manufactures and distributes the Conception Kit® at-home system, a safe, effective, and reasonably priced method to help women and couples over...


Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Consumer-Purchaser Disclosure Project

2nd Opinion Stock Research


More From BioPortfolio on "Role Response Perceptions Couples Ongoing Cancer Related Disclosure"

Quick Search


Corporate Database Quicklinks